Cointime

Cytrellis Biosystems

company

About

Cytrellis is a medical technology company that develops aesthetic devices.

  • 1 - 10

Highlights

Total Funding Amount
$85.63M
Funding Rounds
3
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$28.50M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Cytrellis Biosystems is a clinical stage medical technology company that designs and develops medical device for dermatology, scar reduction, and aesthetic medicine. Its devices are designed to remove sagging skin associated with aging without surgery or scarring, providing aesthetic practitioners an unprecedented ability to improve age related changes in skin.

Cytrellis Biosystems was founded in 2011 and is based in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$85.63M
Cytrellis Biosystems has raised a total of $85.63M in funding over 2 rounds. Their latest funding was raised on Jan 4, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 4, 2021 Series C $49.99M 1 — — Detail
Jun 5, 2018 Series B $28.50M 1 — — Detail
Feb 20, 2015 Series A $7.14M 1 ARCH Venture Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cytrellis Biosystems is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners — Series C
Cointime
Chủ Đề
Công Ty